
UnitedHealth (UNH) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
111.6B
Gross Profit
20.0B
17.93%
Operating Income
5.2B
4.61%
Net Income
3.6B
3.20%
EPS (Diluted)
$3.74
Balance Sheet Metrics
Total Assets
309.8B
Total Liabilities
204.6B
Shareholders Equity
105.2B
Debt to Equity
1.95
Cash Flow Metrics
Operating Cash Flow
2.4B
Free Cash Flow
4.6B
Revenue & Profitability Trend
UnitedHealth Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 400.3B | 367.5B | 322.1B | 285.3B | 255.6B |
Cost of Goods Sold | 310.9B | 280.7B | 244.5B | 217.9B | 190.1B |
Gross Profit | 89.4B | 86.9B | 77.6B | 67.3B | 65.5B |
Gross Margin % | 22.3% | 23.6% | 24.1% | 23.6% | 25.6% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | - | - | - | - |
Other Operating Expenses | 53.0B | 54.6B | 47.8B | 42.6B | 41.7B |
Total Operating Expenses | 53.0B | 54.6B | 47.8B | 42.6B | 41.7B |
Operating Income | 32.3B | 28.3B | 26.4B | 21.6B | 20.9B |
Operating Margin % | 8.1% | 7.7% | 8.2% | 7.6% | 8.2% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | 3.9B | 3.2B | 2.1B | 1.7B | 1.7B |
Other Non-Operating Income | -8.3B | 4.1B | 2.0B | 2.3B | 1.5B |
Pre-tax Income | 20.1B | 29.1B | 26.3B | 22.3B | 20.7B |
Income Tax | 4.8B | 6.0B | 5.7B | 4.6B | 5.0B |
Effective Tax Rate % | 24.1% | 20.5% | 21.7% | 20.5% | 24.0% |
Net Income | 15.2B | 23.1B | 20.6B | 17.7B | 15.8B |
Net Margin % | 3.8% | 6.3% | 6.4% | 6.2% | 6.2% |
Key Metrics | |||||
EBITDA | 36.4B | 32.2B | 29.8B | 24.7B | 23.8B |
EPS (Basic) | $15.64 | $24.12 | $21.54 | $18.33 | $16.28 |
EPS (Diluted) | $15.51 | $23.86 | $21.18 | $18.08 | $16.03 |
Basic Shares Outstanding | 921000000 | 928000000 | 934000000 | 943000000 | 946000000 |
Diluted Shares Outstanding | 921000000 | 928000000 | 934000000 | 943000000 | 946000000 |
Income Statement Trend
UnitedHealth Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 25.3B | 25.4B | 23.4B | 21.4B | 16.9B |
Short-term Investments | 3.8B | 4.2B | 4.5B | 2.5B | 2.9B |
Accounts Receivable | 22.4B | 21.3B | 17.7B | 14.2B | 12.9B |
Inventory | - | - | - | - | - |
Other Current Assets | 8.2B | 9.8B | 10.7B | 9.8B | 8.5B |
Total Current Assets | 85.8B | 78.4B | 69.1B | 61.8B | 53.7B |
Non-Current Assets | |||||
Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 |
Goodwill | 236.7B | 222.7B | 201.1B | 161.6B | 153.5B |
Intangible Assets | 23.3B | 15.2B | 14.4B | 10.0B | 10.9B |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 19.6B | 17.3B | 15.0B | 12.5B | 11.5B |
Total Non-Current Assets | 212.5B | 195.3B | 176.6B | 150.4B | 143.6B |
Total Assets | 298.3B | 273.7B | 245.7B | 212.2B | 197.3B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 68.6B | 64.4B | 56.8B | 49.1B | 44.4B |
Short-term Debt | 4.5B | 4.3B | 3.1B | 3.6B | 4.8B |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 27.3B | 27.1B | 26.3B | 23.0B | 20.4B |
Total Current Liabilities | 103.8B | 99.1B | 89.2B | 78.3B | 72.4B |
Non-Current Liabilities | |||||
Long-term Debt | 72.4B | 58.3B | 54.5B | 42.4B | 38.6B |
Deferred Tax Liabilities | 3.6B | 3.0B | 2.8B | 3.3B | 3.4B |
Other Non-Current Liabilities | 15.9B | 14.5B | 12.8B | 11.8B | 12.3B |
Total Non-Current Liabilities | 91.9B | 75.7B | 70.1B | 57.4B | 54.3B |
Total Liabilities | 195.7B | 174.8B | 159.4B | 135.7B | 126.8B |
Equity | |||||
Common Stock | 9.0M | 9.0M | 9.0M | 10.0M | 10.0M |
Retained Earnings | 96.0B | 95.8B | 86.2B | 77.1B | 69.3B |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 102.6B | 98.9B | 86.3B | 76.5B | 70.5B |
Key Metrics | |||||
Total Debt | 76.9B | 62.5B | 57.6B | 46.0B | 43.5B |
Working Capital | -18.0B | -20.6B | -20.2B | -16.5B | -18.7B |
Balance Sheet Composition
UnitedHealth Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 15.2B | 23.1B | 20.6B | 17.7B | 15.8B |
Depreciation & Amortization | 4.1B | 4.0B | 3.4B | 3.1B | 2.9B |
Stock-Based Compensation | 1.0B | 1.1B | 925.0M | 800.0M | 679.0M |
Working Capital Changes | -3.3B | -1.8B | -3.2B | -2.2B | 2.7B |
Operating Cash Flow | 13.4B | 25.6B | 20.8B | 18.6B | 22.0B |
Investing Activities | |||||
Capital Expenditures | -3.5B | -3.4B | -2.8B | -2.5B | -2.1B |
Acquisitions | -13.4B | -10.1B | -21.5B | -4.8B | -7.1B |
Investment Purchases | -27.3B | -18.3B | -18.8B | -17.1B | -16.6B |
Investment Sales | 27.8B | 16.5B | 12.0B | 15.3B | 13.7B |
Investing Cash Flow | -20.5B | -15.6B | -28.5B | -10.4B | -12.5B |
Financing Activities | |||||
Share Repurchases | -9.0B | -8.0B | -7.0B | -5.0B | -4.2B |
Dividends Paid | -7.5B | -6.8B | -6.0B | -5.3B | -4.6B |
Debt Issuance | 17.8B | 6.4B | 14.8B | 6.9B | 4.9B |
Debt Repayment | -3.0B | -2.1B | -3.0B | -3.2B | -3.2B |
Financing Cash Flow | -3.5B | -11.5B | 4.2B | -7.5B | -3.6B |
Free Cash Flow | 20.7B | 25.7B | 23.4B | 19.9B | 20.1B |
Net Change in Cash | -10.6B | -1.5B | -3.5B | 784.0M | 5.9B |
Cash Flow Trend
UnitedHealth Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
11.69
Forward P/E
9.03
Price to Book
2.58
Price to Sales
0.58
PEG Ratio
-0.66
Profitability Ratios
Profit Margin
5.04%
Operating Margin
4.61%
Return on Equity
21.65%
Return on Assets
6.46%
Financial Health
Current Ratio
0.85
Debt to Equity
75.58
Beta
0.44
Per Share Data
EPS (TTM)
$23.10
Book Value per Share
$104.67
Revenue per Share
$461.84
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
unh | 244.5B | 11.69 | 2.58 | 21.65% | 5.04% | 75.58 |
CVS Health | 83.1B | 18.25 | 1.07 | 5.88% | 1.18% | 106.67 |
Cigna | 74.9B | 15.39 | 1.86 | 13.18% | 1.92% | 76.10 |
Elevance Health | 65.9B | 12.40 | 1.50 | 12.42% | 2.83% | 68.84 |
Humana | 33.9B | 21.59 | 1.86 | 9.03% | 1.28% | 70.63 |
Centene | 12.9B | 6.35 | 0.47 | 7.44% | 1.29% | 63.91 |
Financial data is updated regularly. All figures are in the company's reporting currency.